Gilead Sciences (GILD) News Today $107.89 +1.15 (+1.08%) Closing price 04:00 PM EasternExtended Trading$107.81 -0.08 (-0.07%) As of 05:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Gilead Sciences Inc (GILD) Tackles Stigma in Lung Cancer with Lessons from HIV EpidemicMarch 25 at 12:39 PM | gurufocus.comGilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Corebridge Financial Inc.Corebridge Financial Inc. trimmed its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 3.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 367,477 shares of the biopharmaceutical companMarch 25 at 6:31 AM | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Recommendation of "Moderate Buy" by AnalystsShares of Gilead Sciences, Inc. (NASDAQ:GILD - Get Free Report) have received an average rating of "Moderate Buy" from the twenty-nine analysts that are presently covering the company, MarketBeat reports. Eleven investment analysts have rated the stock with a hold recommendation, fifteen have givenMarch 25 at 4:55 AM | marketbeat.comCrowley Wealth Management Inc. Purchases Shares of 2,480 Gilead Sciences, Inc. (NASDAQ:GILD)Crowley Wealth Management Inc. bought a new stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 2,480 shares of the biopharmaceutical company's stock,March 24 at 7:18 AM | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Vanguard Group Inc.Vanguard Group Inc. lifted its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 0.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 115,528,392 shares of the biopharmaceutical cMarch 24 at 7:07 AM | marketbeat.comSimplify Asset Management Inc. Has $4.26 Million Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)Simplify Asset Management Inc. lowered its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 52.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 46,167 shares of the biopharmaceuMarch 24 at 6:18 AM | marketbeat.comBlueprint Investment Partners LLC Raises Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)Blueprint Investment Partners LLC increased its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 59.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 6,771 shares of the biopharmaceuticaMarch 24 at 6:12 AM | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Holdings Lifted by American Century Companies Inc.American Century Companies Inc. boosted its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 16.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,051,517 shares of the biopharmaMarch 24 at 5:33 AM | marketbeat.comHillsdale Investment Management Inc. Acquires Shares of 8,800 Gilead Sciences, Inc. (NASDAQ:GILD)Hillsdale Investment Management Inc. bought a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 8,800 sharesMarch 24 at 5:11 AM | marketbeat.comSei Investments Co. Has $70.24 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Sei Investments Co. grew its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 18.1% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 760,358 shares of the biopharmaceutical company's stock after purchasing an additionaMarch 24 at 5:10 AM | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by HUB Investment Partners LLCHUB Investment Partners LLC lessened its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 64.0% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 2,636 shares of the biopharmaceutical company's stock after selling 4,682 shares during the period. HUMarch 24 at 4:58 AM | marketbeat.comGilead: Expansion Of Livdelzi For PBC Continues With European Marketing ApprovalMarch 23 at 1:38 PM | seekingalpha.comKLP Kapitalforvaltning AS Acquires Shares of 754,608 Gilead Sciences, Inc. (NASDAQ:GILD)KLP Kapitalforvaltning AS acquired a new stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 754,608 shares of the biopharmaceutiMarch 23 at 7:13 AM | marketbeat.comFi3 FINANCIAL ADVISORS LLC Purchases Shares of 2,386 Gilead Sciences, Inc. (NASDAQ:GILD)Fi3 FINANCIAL ADVISORS LLC purchased a new stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 2,386 shares of the biopharmaceutical company's stock, valued at approximatelyMarch 23 at 6:16 AM | marketbeat.comMizuho Securities USA LLC Has $10.91 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Mizuho Securities USA LLC lifted its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 46.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 118,118 shares of the biopharmaceutical company's stock after purMarch 23 at 6:16 AM | marketbeat.comZEGA Investments LLC Buys Shares of 6,047 Gilead Sciences, Inc. (NASDAQ:GILD)ZEGA Investments LLC acquired a new stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 6,047 shares of the biopharmaceutical company's stMarch 23 at 6:00 AM | marketbeat.comSummit Global Investments Acquires New Stake in Gilead Sciences, Inc. (NASDAQ:GILD)Summit Global Investments acquired a new stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 51,080 shares of the biopharmaceutical companyMarch 23 at 5:49 AM | marketbeat.com2,582 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Bought by Wayfinding Financial LLCWayfinding Financial LLC purchased a new stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 2,582 shares of the biopharmaceutical company's stoMarch 23 at 5:40 AM | marketbeat.comTD Private Client Wealth LLC Sells 4,004 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)TD Private Client Wealth LLC decreased its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 7.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 53,505 shares of the biopharmaceutical comMarch 23 at 5:31 AM | marketbeat.comSector Gamma AS Has $18.24 Million Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)Sector Gamma AS decreased its holdings in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 31.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 197,500 shares of the biopharmaceutical company's stock after selling 91,663 shares during theMarch 22 at 6:52 AM | marketbeat.comCommonwealth of Pennsylvania Public School Empls Retrmt SYS Has $24.48 Million Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Commonwealth of Pennsylvania Public School Empls Retrmt SYS lowered its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 2.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 264,993 shares of theMarch 22 at 5:21 AM | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by Teacher Retirement System of TexasTeacher Retirement System of Texas lifted its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 32.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 442,579 shares of the biopharmaceutical company's stock after purchasing anMarch 22 at 5:11 AM | marketbeat.comOVERSEA CHINESE BANKING Corp Ltd Invests $670,000 in Gilead Sciences, Inc. (NASDAQ:GILD)OVERSEA CHINESE BANKING Corp Ltd purchased a new stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 7,253 shares of the biopharMarch 22 at 5:02 AM | marketbeat.comTruist Financial Sticks to Its Hold Rating for Gilead Sciences (GILD)March 21, 2025 | markets.businessinsider.comGilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Northwest & Ethical Investments L.P.Northwest & Ethical Investments L.P. lifted its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 4.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 244,195 shares of theMarch 21, 2025 | marketbeat.comLingohr Asset Management GmbH Invests $796,000 in Gilead Sciences, Inc. (NASDAQ:GILD)Lingohr Asset Management GmbH acquired a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 8,647 shares of the biMarch 21, 2025 | marketbeat.comiA Global Asset Management Inc. Increases Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)iA Global Asset Management Inc. lifted its holdings in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 14.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 199,882 shares of the biopharmaceutical cMarch 21, 2025 | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Position Lowered by Royal London Asset Management Ltd.Royal London Asset Management Ltd. lowered its holdings in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 19.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 706,765 shares of the biopharmaceutical companyMarch 21, 2025 | marketbeat.comMaryland State Retirement & Pension System Has $6.20 Million Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)Maryland State Retirement & Pension System cut its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 6.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 67,136 shares of the biopharmaceutical company's stock aftMarch 21, 2025 | marketbeat.comGilead Sciences (NASDAQ:GILD) Stock Price Down 3% - Should You Sell?Gilead Sciences (NASDAQ:GILD) Stock Price Down 3% - Here's What HappenedMarch 20, 2025 | marketbeat.comGenerali Investments Management Co LLC Makes New $1.10 Million Investment in Gilead Sciences, Inc. (NASDAQ:GILD)Generali Investments Management Co LLC purchased a new position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 11,855 shares of the biopharmaceuticaMarch 20, 2025 | marketbeat.comHarvest Fund Management Co. Ltd Boosts Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)Harvest Fund Management Co. Ltd raised its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 41.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 80,889 shares of the biopharmaceutical company's stock aftMarch 20, 2025 | marketbeat.comKoss Olinger Consulting LLC Purchases 6,782 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Koss Olinger Consulting LLC boosted its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 21.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 38,249 shares of the biopharmaceuticalMarch 20, 2025 | marketbeat.comVinva Investment Management Ltd Decreases Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Vinva Investment Management Ltd trimmed its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 9.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 84,553 shares of the biopharmaceutical company's sMarch 20, 2025 | marketbeat.comNorth Forty Two & Co. Makes New $573,000 Investment in Gilead Sciences, Inc. (NASDAQ:GILD)North Forty Two & Co. bought a new position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 6,205 shares of the biopharmaceutical company's stock, valued at approxMarch 20, 2025 | marketbeat.comTrillium Asset Management LLC Sells 10,464 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Trillium Asset Management LLC decreased its holdings in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 6.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 145,453 shares of the biopharmaceutical company's stock afterMarch 20, 2025 | marketbeat.comWhy Gilead Sciences (GILD) Is Among the Most Undervalued Biotech Stocks to Invest InMarch 20, 2025 | msn.comGilead stock falls on report of HIV prevention cutsMarch 19, 2025 | ca.finance.yahoo.comWells Fargo Keeps Their Buy Rating on Gilead Sciences (GILD)March 19, 2025 | markets.businessinsider.comGilead Stock Falls on Report Trump Administration Wants to Cut HIV-Prevention FundingMarch 19, 2025 | barrons.comGilead Sciences: Buy Rating Affirmed Amid Minimal Impact from CDC Budget CutsMarch 19, 2025 | tipranks.comIntech Investment Management LLC Buys 3,038 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Intech Investment Management LLC increased its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 1.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 195,587 shares of the biopharmaceutical company's stock after purchasinMarch 19, 2025 | marketbeat.comGilead Stock (NYSE:GILD) Slumps on HIV Funding Cuts ReportMarch 19, 2025 | tipranks.comAdvisors Asset Management Inc. Sells 29,260 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Advisors Asset Management Inc. lowered its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 11.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 225,576 shares of the biopharmaceutical company'March 19, 2025 | marketbeat.comThrivent Financial for Lutherans Sells 1,000,775 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Thrivent Financial for Lutherans lessened its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 45.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,186,671 shares of the biopharmaceutical company's stock afteMarch 19, 2025 | marketbeat.com4,625 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Acquired by Haven Capital Group Inc.Haven Capital Group Inc. bought a new stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 4,625 shares of the biopharmaceutical company's stock, valued at approMarch 19, 2025 | marketbeat.comRoyce & Associates LP Sells 10,000 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Royce & Associates LP cut its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 12.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 70,000 shares of the biopharmaceutical company's stock afterMarch 19, 2025 | marketbeat.comGilead Sciences stock falls on potential HIV funding cutsMarch 18, 2025 | in.investing.comUnpacking the Latest Options Trading Trends in Gilead SciencesMarch 18, 2025 | benzinga.comParallel Advisors LLC Reduces Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)Parallel Advisors LLC reduced its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 5.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 37,040 shares of the biopharmaceutical compaMarch 18, 2025 | marketbeat.com Remove Ads Get Gilead Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GILD and its competitors with MarketBeat's FREE daily newsletter. Email Address GILD Media Mentions By Week GILD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GILD News Sentiment▼1.160.62▲Average Medical News Sentiment GILD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GILD Articles This Week▼4926▲GILD Articles Average Week Remove Ads Get Gilead Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GILD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AMGN News Today VRTX News Today REGN News Today ALNY News Today BIIB News Today UTHR News Today BMRN News Today INCY News Today NBIX News Today EXEL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GILD) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gilead Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gilead Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GILD Stock Free GILD Stock Alerts